Matches in Wikidata for { <http://www.wikidata.org/entity/Q92508149> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92508149 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92508149 description "scientific article published on 30 June 2019" @default.
- Q92508149 description "wetenschappelijk artikel" @default.
- Q92508149 description "наукова стаття, опублікована 30 червня 2019" @default.
- Q92508149 name "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 name "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 type Item @default.
- Q92508149 label "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 label "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 prefLabel "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 prefLabel "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 P1433 Q92508149-A22CD7F0-C18C-4C9F-94A3-F575ED3691A9 @default.
- Q92508149 P1476 Q92508149-A92EEE75-5E67-4E9B-B220-CC8DA188BFB8 @default.
- Q92508149 P2093 Q92508149-D67DD940-BD18-410F-A9D5-9CE44AECCA80 @default.
- Q92508149 P2093 Q92508149-DCCEC11F-38E9-45E9-9AD8-FE168F694FD9 @default.
- Q92508149 P2093 Q92508149-EEA20B5B-B43D-4BA0-9926-F064C31D71F6 @default.
- Q92508149 P2093 Q92508149-FA5A9462-8A64-47DB-9C2C-3A83D6F814C3 @default.
- Q92508149 P304 Q92508149-7893F8BA-8957-45AC-BEB5-96885384B6F7 @default.
- Q92508149 P31 Q92508149-6290CCAA-AEE0-4F5C-87BC-779E435CCF8F @default.
- Q92508149 P356 Q92508149-30341B03-0FF2-487B-AAEA-48ED2FB5835F @default.
- Q92508149 P433 Q92508149-606B2AF3-CFA3-4FA3-A79D-BD637C6434E3 @default.
- Q92508149 P478 Q92508149-FFF911EC-7FA6-4CF0-AE4B-D21DF58EAC2B @default.
- Q92508149 P50 Q92508149-D55BFAB9-8F2C-4896-9335-189D3842DAEF @default.
- Q92508149 P577 Q92508149-417F00F0-71B3-4E64-9551-D3A5DF0C069F @default.
- Q92508149 P698 Q92508149-F129B921-9497-4C4D-8F65-5B4E5C5A4DEE @default.
- Q92508149 P921 Q92508149-61C0DFE9-5721-4883-830E-8CAD844A87BD @default.
- Q92508149 P921 Q92508149-733D933D-7595-434D-B5F0-51E9BFC57191 @default.
- Q92508149 P356 DOM.13801 @default.
- Q92508149 P698 31161692 @default.
- Q92508149 P1433 Q5270109 @default.
- Q92508149 P1476 "A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults" @default.
- Q92508149 P2093 "Fang Zhu" @default.
- Q92508149 P2093 "John P Lock" @default.
- Q92508149 P2093 "Wenjiong Zhou" @default.
- Q92508149 P2093 "Yuan-Di Halvorsen" @default.
- Q92508149 P304 "2248-2256" @default.
- Q92508149 P31 Q13442814 @default.
- Q92508149 P356 "10.1111/DOM.13801" @default.
- Q92508149 P433 "10" @default.
- Q92508149 P478 "21" @default.
- Q92508149 P50 Q91364980 @default.
- Q92508149 P577 "2019-06-30T00:00:00Z" @default.
- Q92508149 P698 "31161692" @default.
- Q92508149 P921 Q19484 @default.
- Q92508149 P921 Q3025883 @default.